Telix Pharmaceuticals Limited
TLPPF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $5,395,320 | $8,015,186 | $6,251,616 | $3,268,700 |
| - Cash | $207,156 | $710,346 | $118,837 | $123,237 |
| + Debt | $418,253 | $581,448 | $22,143 | $17,445 |
| Enterprise Value | $5,606,417 | $7,886,288 | $6,154,922 | $3,162,908 |
| Revenue | $593,111 | $594,244 | $188,963 | $281,713 |
| % Growth | -0.2% | 214.5% | -32.9% | – |
| Gross Profit | $288,343 | $385,797 | $123,881 | $223,975 |
| % Margin | 48.6% | 64.9% | 65.6% | 79.5% |
| EBITDA | $8,905 | $76,800 | $40,291 | $22,994 |
| % Margin | 1.5% | 12.9% | 21.3% | 8.2% |
| Net Income | -$3,482 | $38,239 | $11,680 | $19,531 |
| % Margin | -0.6% | 6.4% | 6.2% | 6.9% |
| EPS Diluted | -0.01 | 0.11 | 0.033 | 0.06 |
| % Growth | -109.4% | 230.3% | -44.8% | – |
| Operating Cash Flow | $26,968 | $9,420 | $33,609 | $10,625 |
| Capital Expenditures | -$10,131 | -$20,336 | -$13,696 | -$7,785 |
| Free Cash Flow | $16,836 | -$10,916 | $19,913 | $2,840 |